Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity
Open Access
- 8 April 2013
- journal article
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 131
Abstract
Multiple sclerosis (MS) is a chronic disease that affects mainly adults in the prime of their lives. However, few studies report the impact of high annual relapse rates on outcomes. The purpose of this study was to identify high relapse activity (HRA) in patients with MS, comparing differences in outcomes between patients with and without HRA.Keywords
This publication has 17 references indexed in Scilit:
- Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal responseEuropean Journal of Neurology, 2012
- Reasons patients give to use or not to use immunomodulating agents for multiple sclerosisEuropean Journal of Neurology, 2011
- Multiple Sclerosis: Is Prevalence Rising and if So WhyNeuroepidemiology, 2011
- Surrogate endpoints for EDSS worsening in multiple sclerosisNeurology, 2010
- Costs and quality of life in multiple sclerosisNeurology, 2006
- Guidelines for selecting among different types of bootstrapsCurrent Medical Research and Opinion, 2006
- Managing symptoms of multiple sclerosisNeurologic Clinics, 2005
- Natural history of multiple sclerosisAnnals of Neurology, 1994
- STUDIES ON THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: 7. Correlates of Clinical Change in an Early BoutActa Neurologica Scandinavica, 1973
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965